跳至主要内容
临床试验/NL-OMON38833
NL-OMON38833撤回不适用

Molecular mechanisms behind presumed reduced ovarian reserve and embryo competence in BRCA1/2-mutation carriers in IVF/PGD - Molecular studies on reduced ovarian reserve in BRCA1/2-mutation carriers

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 245 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
入组人数
245

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational non invasive

入排标准

年龄范围
18 至 99(—)

入选标准

  • - IVF/PGD treatment for a BRCA1/2 mutation, both female and male mutation carriers
  • - IVF/PGD treatment because of an autosomal dominant genetic disorder transmitted by the male
  • - IVF treatment, including ICSI, for male subfertility

排除标准

  • - Previous diagnosis of female subfertility in controls
  • - Known hereditary disease other than due to BRCA1/2-mutations in the female
  • - Known history of a malignancy in the female
  • - History of cancer treatment in the female
  • - Non-Dutch couples, not able to understand the patient information to give
  • informed consent properly

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

相似试验